Rationality of the FIGO2023 staging for early-stage endometrial cancer, compared with the FIGO2009 staging
Objective The International Federation of Gynecology and Obstetrics (FIGO) released a new staging for endometrial cancer (EC), which revised the FIGO2009 staging to include histopathological and molecular features. The purpose of this study was to validate the prognostic accuracy of the new staging...
Saved in:
| Main Authors: | Yiqin Wang, Jianliu Wang, Xingchen Li, Aoxuan Zhu, Yangyang Dong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-04-01
|
| Series: | Gynecology and Obstetrics Clinical Medicine |
| Online Access: | https://gocm.bmj.com/content/4/1/e000016.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The new FIGO 2023 staging reclassification of patients with FIGO 2009 Stage IVB endometrial cancer correlates to progression-free and overall survival outcomes
by: Monal Garg, et al.
Published: (2024-12-01) -
Prognostic parameters in FIGO stage I endometrial carcinoma of endometrioid type
by: Stanojević Zorica, et al.
Published: (2006-01-01) -
Comparative analysis of hysterectomy types and approaches on oncological survival in 2023 FIGO stage II endometrial carcinoma
by: Jianhao Sun, et al.
Published: (2025-05-01) -
Reviewing FIGO 2018 cervical cancer staging
by: Leila Cristina Soares, et al.
Published: (2023-12-01) -
Role of locoregional surgery in treating FIGO 2009 stage IVB cervical cancer patients: a population-based study
by: Yanhong Wang, et al.
Published: (2021-08-01)